Biomedical Engineering Reference
In-Depth Information
96. Torres-Lugo, M., García, M., Record, R., Peppas, N.A. Physicochemical behavior and cytotoxic effects
of p(methacrylic acid-
g
-ethylene glycol) nanospheres for oral delivery of proteins.
J. Con. Rel
., 80, 197,
2002.
97. Ranjha, N.M., Doelkar, M. pH sensitive hydrogels for site specifi c delivery. I. swelling behavior of
crosslinked copolymers of acrylic acid and methacrylic acid.
S.T.P Pharm. Sci
., 9, 335, 1999.
98. Lowman, A.M. et al. Oral delivery of insulin using pH responsive complexation gels.
J. Pharm. Sci
., 88,
933, 1999.
99. Foss, A.C., Goto, T., Morishita, M., Peppas, N.A. Development of acrylic-based copolymers for oral
insulin delivery.
Eur. J. Pharm. Biopharm
., 57, 163, 2004.
100. Morishita, M. et al. Novel oral insulin delivery systems based on complexation polymer hydrogels:
single and multiple administration studies in type 1 and 2 diabetic
rats.
J. Con. Rel
., 110, 587, 2006.
101. Morishita, I. et al. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in
normal and diabetic rats.
Int. J. Pharm
., 78, 9, 1992.
102. Hosny, E.A., Al-Shora, H.I., Elmazar, M.M.A. Oral delivery of insulin from enteric-coated capsules
containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs.
Int. J. Pharm
.,
237, 71, 2002.
103. Jain, D., Panda, A.K., Majumdar, D.K. Eudragit S100 entrapped insulin microspheres for oral delivery.
AAPS Pharm. Sci. Tech
., 6, E100, 2005.
104. Paul, W., Sharma, C.P. Chitosan, a drug carrier for 21st century: a review.
STP Pharm. Sci
., 10, 5, 2000.
105. Rao, S.B., Sharma, C.P. Use of chitosan as a biomaterial: studies on its safety and haemostatic potential.
J. Biomat. Mat. Res
.,
34, 21, 1997.
106. Berger, J. et al. Structure and interactions in chitosan hydrogels formed by complexation or aggregation
for biomedical applications.
Eur. J. Pharm. Biopharm
., 57, 35, 2004.
107. Kas, H.S. Chitosan: properties, preparations and application to microparticulate systems.
J. Microen-
cap
., 14, 689, 1997.
108. Agnihotri, S., Mallikarjuna, N.N., Aminabhavi, T.M. Recent advances on chitosan-based micro-and
nanoparticles in drug delivery.
J. Con. Del
., 100, 5, 2004.
109. Illum, L. Chitosan and its use as a pharmaceutical excipient.
Pharm. Res
., 15, 1326, 1998.
110. Thanou, M., Verhoef, J.C., Junginger, H.E. Chitosan and its derivatives as intestinal absorption enhanc-
ers.
Adv. Drug Del. Rev
., 50, S91, 2001.
111. Schipper, N.G.M. et al. Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of
absorption enhancement.
Pharm. Res
., 14, 923, 1997.
112. Artursson, P., Lindmark, T., Davis, S.S., Illum, L. Effect of chitosan on the permeability of monolayer
of intestinal epithelial cells (caco-2).
Pharm. Res
., 11, 1358, 1994.
113. Ma, Z., Lim, L.Y. Uptake of chitosan and associated insulin in caco 2 cell monolayers: a comparison
between chitosan molecules and chitosan nanoparticles.
Pharm. Res
., 20, 1812, 2003.
114. Kotze, A.F. et a l.
N
-trimethyl chitosan chloride as a potential absorption enhancer across mucosal sur-
faces:
in vitro
evaluation in intestinal epithelial cells (caco-2).
Pharm. Res
., 14, 1197, 1997.
115. Thanou, M. et al.
N
-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the
peptide drug buserelin
in vitro
(caco-2 cells) and
in vivo
(rats
)
Pharm. Res
.,
17, 27, 2000.
116. Prego, C., Torres, D., Alonso, M.J. Chitosan nanocapsules as carriers for oral peptide delivery: effect of
chitosan molecular weight and type of salt on the
in vitro
behavior and
in vivo
effectiveness.
Nanosci.
Nanotechnol
., 6, 2921, 2006.
117. Pan, Y. et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the
intestinal absorption of insulin
in vivo
.
Int. J. Pharm
., 249, 139, 2002.
118. Tozaki, H. et al. Chitosan capsules for colon drug delivery: improvement of insulin absorption from rat
colon,
J. Pharm. Sci
., 86, 1016, 1997.
119. Lubben, I.M.V. et al. Chitosan microparticles for oral vaccination: preparation characterization and
preliminary
in vivo
uptake studies in murine payer's patches.
Biomaterials
, 22, 687, 2001.
120. Tønnesen, H.H., Karlsen, J. Alginate in drug delivery systems.
Drug Dev. Ind. Pharm
., 28, 621, 2002.
121. Gombotzb, W.R., Wee, S.W. Protein release from alginate matrices.
Adv. Drug Del Rev
., 31, 267, 1998.
122. Liu, P., Krishnan, T.R. Alginate-pectin-poly-l-lysine particulate as a potential controlled release formu-
lation.
J. Pharm. Pharmcol
., 51, 141, 1999.
123. Hari, P.R., Chandy, T., Sharma, C.P. Chitosan/calcium alginate beads for oral delivery of insulin.
J. Appl. Pol. Sci
., 59, 1795, 1996.
124. Dileep, K.J., Roswen M.L., Sharma, C.P. Modulation of insulin from chitosan/alginate microspheres.
Trends Biomat. Art. Organs
, 12, 42, 1998.
